Cardiovascular Systems soars on earnings beat, upgrade

Cardiovascular Systems (CSII +11.2%) posts double-digit gains following the company's FQ4 beat.

Revenue growth was 26% for the period.

FQ1 outlook: Net loss of $0.39-0.42/ share on revenue of $27.5-28.5M against consensus of a $0.31/ share loss on sales of $26.12M.

Feltl upgrades the shares to Strong Buy.

Conference call transcript

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs